Evidence map›Paper›PMID 39753613›Full record

ArticleScientific reports2025

Design, synthesis, in vitro, and in silico studies of 4-fluorocinnamaldehyde based thiosemicarbazones as urease inhibitors.

Muhammad Islam, Saeed Ullah, Ajmal Khan, Zahra Batool, Suraj N Mali, Shailesh S Gurav, Kholood A Dahlous, Saikh Mohammad, Javid Hussain, Ahmed Al-Harrasi and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. RSC advances · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Muhammad IslamDepartment of Basic Sciences and Humanities (Chemistry), Muhammad Nawaz Sharif University of Engineering and Technology (MNSUET), 60000, Multan, Pakistan.
Saeed UllahNatural and Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa, PC 616, Sultanate of Oman.
Ajmal KhanNatural and Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa, PC 616, Sultanate of Oman.
Zahra BatoolInstitute of Chemical Sciences, Bahauddin Zakariya University, 60800, Multan, Pakistan.
Suraj N MaliSchool of Pharmacy, D.Y. Patil University (Deemed to be University), Sector 7, Nerul, Navi, Mumbai, 400706, India.
Shailesh S GuravDepartment of Chemistry, VIVA College, Virar, Maharashtra, India.
Kholood A DahlousDepartment of Chemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Saikh MohammadDepartment of Chemistry, College of Science, King Saud University, Riyadh, 11451, Saudi Arabia.
Javid HussainDepartment of Biological Sciences and Chemistry, University of Nizwa, Nizwa, Oman.
Ahmed Al-HarrasiNatural and Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa, PC 616, Sultanate of Oman. aharrasi@unizwa.edu.om.
Zahid ShafiqDepartment of Chemical and Biological Engineering, College of Engineering, Korea University, Seoul, 02841, Republic of Korea. zahidshafiq@bzu.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinically significant problems such as kidney stones and stomach ulcers are linked to the activation of the urease enzyme. At low pH, this enzyme gives an ideal environment to Helicobacter pylori in the stomach which is the cause of gastric ulcers and peptic ulcers. In recent work, we have developed a library of 4-fluorocinnamaldehyde base thiosemicarbazones and assessed them for their potential against urease enzyme. The synthesized compounds displayed significant to moderate inhibition potential with IC

Indexed as

Drug DesignEnzyme InhibitorsMolecular Docking SimulationThiosemicarbazonesUreaseCatalytic DomainComputer SimulationHelicobacter pyloriHumansKineticsStructure-Activity RelationshipEnzyme InhibitorsThiosemicarbazonesUrease4-fluorocinnamaldehydeADMEDockingFMOThiosemicarbazonesUrease inhibition

Identifiers

PMID39753613
PMCPMC11698833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.